These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 3006784

  • 1. Effect of diabetes and Sorbinil treatment on phospholipid metabolism in rat glomeruli.
    Cohen MP, Klepser H, Cua E.
    Biochim Biophys Acta; 1986 Apr 15; 876(2):226-32. PubMed ID: 3006784
    [Abstract] [Full Text] [Related]

  • 2. Glomerular Na+-K+-ATPase activity in acute and chronic diabetes and with aldose reductase inhibition.
    Cohen MP, Klepser H.
    Diabetes; 1988 May 15; 37(5):558-62. PubMed ID: 2834250
    [Abstract] [Full Text] [Related]

  • 3. Aldose reductase, glomerular metabolism, and diabetic nephropathy.
    Cohen MP.
    Metabolism; 1986 Apr 15; 35(4 Suppl 1):55-9. PubMed ID: 3007926
    [Abstract] [Full Text] [Related]

  • 4. Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil.
    Beyer-Mears A, Ku L, Cohen MP.
    Diabetes; 1984 Jun 15; 33(6):604-7. PubMed ID: 6427041
    [Abstract] [Full Text] [Related]

  • 5. Reduced glomerular sodium/potassium adenosine triphosphatase activity in acute streptozocin diabetes and its prevention by oral sorbinil.
    Cohen MP, Dasmahapatra A, Shapiro E.
    Diabetes; 1985 Nov 15; 34(11):1071-4. PubMed ID: 2995180
    [Abstract] [Full Text] [Related]

  • 6. Na+-K+-ATPase pumping activity is not directly linked to myo-inositol levels after sorbinil treatment in lenses of diabetic rats.
    Yeh LA, Rafford CE, Goddu KJ, Ashton MA, Beyer TA, Hutson NJ.
    Diabetes; 1987 Dec 15; 36(12):1414-9. PubMed ID: 2824260
    [Abstract] [Full Text] [Related]

  • 7. Decreased myo-inositol content and Na+-K+-ATPase activity in superior cervical ganglion of STZ-diabetic rat and prevention by aldose reductase inhibition.
    Greene DA, Mackway AM.
    Diabetes; 1986 Oct 15; 35(10):1106-8. PubMed ID: 3019804
    [Abstract] [Full Text] [Related]

  • 8. Effect of myo-inositol on renal Na-K-ATPase in experimental diabetes.
    Cohen RA, MacGregor LC, Spokes KC, Silva P, Epstein FH.
    Metabolism; 1990 Oct 15; 39(10):1026-32. PubMed ID: 2170818
    [Abstract] [Full Text] [Related]

  • 9. Sorbinil suppresses glomerular prostaglandin production in the streptozotocin diabetic rat.
    Craven PA, DeRubertis FR.
    Metabolism; 1989 Jul 15; 38(7):649-54. PubMed ID: 2500578
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study.
    Obrosova IG, Fathallah L.
    Diabetologia; 2000 Aug 15; 43(8):1048-55. PubMed ID: 10990083
    [Abstract] [Full Text] [Related]

  • 11. Effect of galactose and glucose levels and sorbinil treatment on myo-inositol metabolism and Na+-K+ pump activity in cultured neuroblastoma cells.
    Yorek MA, Dunlap JA, Leeney EM.
    Diabetes; 1989 Aug 15; 38(8):996-1004. PubMed ID: 2546844
    [Abstract] [Full Text] [Related]

  • 12. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.
    Gillon KR, Hawthorne JN, Tomlinson DR.
    Diabetologia; 1983 Oct 15; 25(4):365-71. PubMed ID: 6416913
    [Abstract] [Full Text] [Related]

  • 13. Action of sorbinil in diabetic peripheral nerve. Relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity.
    Greene DA, Lattimer SA.
    Diabetes; 1984 Aug 15; 33(8):712-6. PubMed ID: 6086432
    [Abstract] [Full Text] [Related]

  • 14. An aldose reductase inhibitor but not myo-inositol blocks enhanced polyphosphoinositide turnover in peripheral nerve from diabetic rats.
    Berti-Mattera L, Day N, Peterson RG, Eichberg J.
    Metabolism; 1996 Mar 15; 45(3):320-7. PubMed ID: 8606638
    [Abstract] [Full Text] [Related]

  • 15. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
    Schmidt RE, Plurad SB, Sherman WR, Williamson JR, Tilton RG.
    Diabetes; 1989 May 15; 38(5):569-79. PubMed ID: 2497038
    [Abstract] [Full Text] [Related]

  • 16. A sodium-pump defect in diabetic peripheral nerve corrected by sorbinil administration: relationship to myo-inositol metabolism and nerve conduction slowing.
    Greene DA.
    Metabolism; 1986 Apr 15; 35(4 Suppl 1):60-5. PubMed ID: 2421135
    [Abstract] [Full Text] [Related]

  • 17. Effect of treating streptozotocin-induced diabetic rats with sorbinil, myo-inositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.
    Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Yorek MA.
    Int J Exp Diabetes Res; 2002 Apr 15; 3(1):21-36. PubMed ID: 11900277
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Uncoupling of attenuated myo-[3H]inositol uptake and dysfunction in Na(+)-K(+)-ATPase pumping activity in hypergalactosemic cultured bovine lens epithelial cells.
    Cammarata PR, Tse D, Yorio T.
    Diabetes; 1991 Jun 15; 40(6):731-7. PubMed ID: 1645682
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.